Social defeat interacts with Disc1 mutations in the mouse to affect behavior

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 337-344

  Haque, F Nipa ^a,b   Lipina, Tatiana V ^c   Roder, John C ^a,c   Wong, Albert H C ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety; Depression; Disc1; Gene environment interactions; Schizophrenia; Social defeat; Stress

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; SUCROSE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DISC1 GENE; FORCED SWIMMING TEST; GENE; GENOTYPE ENVIRONMENT INTERACTION; LATENT INHIBITION; LOCOMOTION; MALE; MAZE TEST; MENTAL STRESS; MOUSE; NONHUMAN; OPEN FIELD TEST; POINT MUTATION; PREPULSE INHIBITION; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL DEFEAT; SOCIAL INTERACTION; STARTLE REFLEX; SUGAR INTAKE; WILD TYPE;

ACOUSTIC STIMULATION; ACOUSTICS; AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; EATING; FEAR; GENE-ENVIRONMENT INTERACTION; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; STRESS, PSYCHOLOGICAL; SUCROSE; TIME FACTORS;

EID: 84862224816     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.037     Document Type: Article

References (83)

1. Gogos J.A., Gerber D.J. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends in Pharmacological Sciences 2006, 27(4):226-233.
2. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nature Reviews Neuroscience 2011, 12(12):707-722.
3. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336(8706):13-16.
4. Rastogi A., Zai C., Likhodi O., Kennedy J.L., Wong A.H. Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophrenia Research 2009, 23:23.
5. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 2000, 9(9):1415-1423.
6. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics 2001, 69(2):428-433.
7. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Human Molecular Genetics 2003, 12(23):3151-3159.
8. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Archives of General Psychiatry 2005, 62(10):1081-1088.
9. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(24):8627-8632.
10. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression: brain morphology and ERK signaling. Human Molecular Genetics 2006, 15(20):3024-3033.
11. Harris S.E., Hennah W., Thomson P.A., Luciano M., Starr J.M., Porteous D.J., et al. Variation in DISC1 is associated with anxiety: depression and emotional stability in elderly women. Molecular Psychiatry 2010, 15(3):232-234.
12. Oh G., Petronis A. Environmental studies of schizophrenia through the prism of epigenetics. Schizophrenia Bulletin 2008, 34(6):1122-1129.
13. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34(1):13-25.
14. Krabbendam L., van Os J. Schizophrenia and urbanicity: a major environmental influence-conditional on genetic risk. Schizophrenia Bulletin 2005, 31(4):795-799.
15. Morgan C., Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma-a critical review. Schizophrenia Bulletin 2007, 33(1):3-10.
16. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives of General Psychiatry 2004, 61(8):774-780.
17. Bebbington P., Jonas S., Kuipers E., King M., Cooper C., Brugha T., et al. Childhood sexual abuse and psychosis: data from a cross-sectional national psychiatric survey in England. British Journal of Psychiatry 2011, 199(1):29-37.
18. Malmstrom M., Sundquist J., Johansson S.E., Johansson L.M. The influence of social deprivation as measured by the CNI on psychiatric admissions. Scandinavian Journal of Public Health 1999, 27(3):189-195.
19. Harley M., Kelleher I., Clarke M., Lynch F., Arseneault L., Connor D., et al. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychological Medicine 2010, 40(10):1627-1634.
20. aan het Rot M., Mathew S.J., Charney D.S. Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 2009, 180(3):305-313.
21. Hyman S.E. How mice cope with stressful social situations. Cell 2007, 131(2):232-234.
22. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):386-389.
23. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297(5582):851-854.
24. Ayhan Y., Sawa A., Ross C.A., Pletnikov M.V. Animal models of gene-environment interactions in schizophrenia. Behavioural Brain Research 2009, 204(2):274-281.
25. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K.L., Nucifora F., et al. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biological Psychiatry 2010, 68(12):1172-1181.
26. Ayhan Y., Abazyan B., Nomura J., Kim R., Ladenheim B., Krasnova I.N., et al. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Molecular Psychiatry 2011, 16(3):293-306.
27. Ibi D., Nagai T., Koike H., Kitahara Y., Mizoguchi H., Niwa M., et al. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behavioural Brain Research 2010, 206(1):32-37.
28. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54(3):387-402.
29. Kudryavtseva N.N., Bakshtanovskaya I.V., Koryakina L.A. Social model of depression in mice of C57BL/6J strain. Pharmacology Biochemistry and Behavior 1991, 38(2):315-320.
30. Kinn A.M., Gronli J., Fiske E., Kuipers S., Ursin R., Murison R., et al. A double exposure to social defeat induces sub-chronic effects on sleep and open field behaviour in rats. Physiology and Behavior 2008, 95(4):553-561.
31. Kudryavtseva N.N. Agonistic behavior: a model, experimental studies, and perspectives. Neuroscience and Behavioral Physiology 2000, 30(3):293-305.
32. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311(5762):864-868.
33. Labrie V., Lipina T., Roder J.C. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology 2008, 200(2):217-230.
34. Labrie V., Fukumura R., Rastogi A., Fick L.J., Wang W., Boutros P.C., et al. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics 2009, 18(17):3227-3243.
35. Lipina T., Labrie V., Weiner I., Roder J. Modulators of the glycine site on NMDA receptors: D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 2005, 179(1):54-67.
36. Willner P. Animal models as simulations of depression. Trends in Pharmacological Sciences 1991, 12(4):131-136.
37. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 1977, 229(2):327-336.
38. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59(12):1151-1159.
39. Wallace D.L., Vialou V., Rios L., Carle-Florence T.L., Chakravarty S., Kumar A., et al. The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior. Journal of Neuroscience 2008, 28(41):10272-10277.
40. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neuroscience and Biobehavioral Reviews 2008, 32(1):20-39.
41. Huppert J.D., Smith T.E. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectrums 2005, 10(9):721-731.
42. Pollack M.H. Comorbid anxiety and depression. Journal of Clinical Psychiatry 2005, 66(Suppl. 8):22-29.
43. Labrie V., Clapcote S.J., Roder J.C. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Pharmacology Biochemistry and Behavior 2009, 91(4):610-620.
44. Hinojosa F.R., Spricigo L., Izidio G.S., Bruske G.R., Lopes D.M., Ramos A. Evaluation of two genetic animal models in behavioral tests of anxiety and depression. Behavioural Brain Research 2006, 168(1):127-136.
45. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156(2-3):234-258.
46. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 1992, 49(3):206-215.
47. Quednow B.B., Wagner M., Westheide J., Beckmann K., Bliesener N., Maier W., et al. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biological Psychiatry 2006, 59(6):536-545.
48. Flood D.G., Gasior M., Marino M.J. Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice. Psychopharmacology 2007, 195(2):203-211.
49. Wynn J.K., Green M.F., Sprock J., Light G.A., Widmark C., Reist C., et al. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophrenia Research 2007, 95(1-3):134-142.
50. Powell S.B., Young J.W., Ong J.C., Caron M.G., Geyer M.A. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behavioural Pharmacology 2008, 19(5-6):562-565.
51. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 2003, 160(4):636-645.
52. Gould T.J., Wehner J.M. Genetic influences on latent inhibition. Behavioral Neuroscience 1999, 113(6):1291-1296.
53. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophrenia Bulletin 2005, 31(1):139-153.
54. Williams J.H., Wellman N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N. Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. British Journal of Psychiatry 1998, 172:243-249.
55. Carrion R.E., Goldberg T.E., McLaughlin D., Auther A.M., Correll C.U., Cornblatt B.A. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. American Journal of Psychiatry 2011, 168(8):806-813.
56. Cornblatt B.A., Keilp J.G. Impaired attention: genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin 1994, 20(1):31-46.
57. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes, Brain and Behavior 2004, 3(5):287-302.
58. Kuroda K., Yamada S., Tanaka M., Iizuka M., Yano H., Mori D., et al. Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Human Molecular Genetics 2011, 20(23):4666-4683.
59. Ibi D., Nagai T., Koike H., Kitahara Y., Mizoguchi H., Niwa M., et al. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behavioural Brain Research 2009, 27:27.
60. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(36):14501-14506.
61. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., et al. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(46):18280-18285.
62. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Molecular Psychiatry 2008, 13(2):173-186.
63. van Zelst C. Which environments for G×E? A user perspective on the roles of trauma and structural discrimination in the onset and course of schizophrenia. Schizophrenia Bulletin 2008, 34(6):1106-1110.
64. van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia Bulletin 2008, 34(6):1066-1082.
65. Pan X.Q., Zhang Y.H., Liu Y.Y., Tong W.J. Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population. European Journal of Epidemiology 2010, 25(11):813-821.
66. Oliver P.L. Challenges of analysing gene-environment interactions in mouse models of schizophrenia. The Scientific World Journal 2011, 11:1411-1420.
67. Charil A., Laplante D.P., Vaillancourt C., King S. Prenatal stress and brain development. Brain Research Reviews 2010, 65(1):56-79.
68. van den Hove D.L., Jakob S.B., Schraut K.G., Kenis G., Schmitt A.G., Kneitz S., et al. Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene×environment interactions. PLoS One 2011, 6(8):e22715.
69. Toki S., Morinobu S., Imanaka A., Yamamoto S., Yamawaki S., Honma K. Importance of early lighting conditions in maternal care by dam as well as anxiety and memory later in life of offspring. European Journal of Neuroscience 2007, 25(3):815-829.
70. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. Maternal care: hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997, 277(5332):1659-1662.
71. Avgustinovich D.F., Lipina T.V., Bondar N.P., Alekseyenko O.V., Kudryavtseva N.N. Features of the genetically defined anxiety in mice. Behavior Genetics 2000, 30(2):101-109.
72. Ma X.C., Jiang D., Jiang W.H., Wang F., Jia M., Wu J., et al. Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS One 2011, 6(6):e20955.
73. Choleris E., Thomas A.W., Kavaliers M., Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neuroscience and Biobehavioral Reviews 2001, 25(3):235-260.
74. Reijmers L.G., Hoekstra K., Burbach J.P., van Ree J.M., Spruijt B.M. Long-term impairment of social memory in the rat after social defeat is not restored by desglycinamide-vasopressin. Neuroscience Letters 2001, 305(3):145-148.
75. Selten J.P., Cantor-Graae E. Social defeat: risk factor for schizophrenia?. British Journal of Psychiatry 2005, 187:101-102.
76. Rubino I.A., Nanni R.C., Pozzi D.M., Siracusano A. Early adverse experiences in schizophrenia and unipolar depression. Journal of Nervous and Mental Disease 2009, 197(1):65-68.
77. Tidey J.W., Miczek K.A. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Research 1996, 721(1-2):140-149.
78. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biological Psychiatry 1999, 46(1):56-72.
79. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156(2-3):117-154.
80. Myin-Germeys I., Peeters F., Havermans R., Nicolson N.A., DeVries M.W., Delespaul P., et al. Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study. Acta Psychiatrica Scandinavica 2003, 107(2):124-131.
81. Paykel E.S. Contribution of life events to causation of psychiatric illness. Psychological Medicine 1978, 8(2):245-253.
82. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310(5751):1187-1191.
83. Li Y.F., Huang Y., Amsdell S.L., Xiao L., O'Donnell J.M., Zhang H.T. Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 2009, 34(11):2404-2419.